| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/06/2002 | EP0703784B1 Release and mobilisation of haematopoietic cells |
| 03/06/2002 | EP0584201B1 Transmission-blocking vaccine against malaria |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |
| 03/06/2002 | CN1338942A Self-emulsifying compositions for drugs poorly soluble in water |
| 03/06/2002 | CN1338937A Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 03/06/2002 | CN1338925A Enteric coated pharmaceutical tablet and method of manufacturing |
| 03/06/2002 | CN1338517A Polypeptide-human dihydropteridine reductase 19.47 and polynucleotide for coding it |
| 03/06/2002 | CN1338516A Polypeptide-human prohormone and proteinogen convertase hPC135.97 and polynucleotide for coding it |
| 03/06/2002 | CN1338463A Method for improving stability of polypeptide in body and its application |
| 03/06/2002 | CN1338305A Matrix metalloprotease tissue depressant for preventing and treating angiostenosis after damage |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080310C Antibiotic wap-8294A, method for preparing the same and antibacterical composition |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/06/2002 | CN1080123C Prolonged delivery of peptides |
| 03/06/2002 | CN1080114C Power formulations containing melezitose as diluent |
| 03/06/2002 | CA2356545A1 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 03/05/2002 | US6353152 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine; |
| 03/05/2002 | US6353098 Synthesis, deprotection, analysis and purification of RNA and ribozymes |
| 03/05/2002 | US6353097 Nucleic acids encoding signal transduction inhibitors of allergic reactions |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353091 A polypeptide; therapy and diagnosis of diseases, strokes, neuropathic pain and traumatic brain injury |
| 03/05/2002 | US6353090 Synthesizing an argenine-glycine-aspartate amino acid ligand with a chemical structure to restrict the conformational stereochemical structure; therapy for thrombosis, metastasis, inflammation, wound healing and rejection of prosthetics |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353005 Treatment of gastrointestinal disorders |
| 03/05/2002 | US6352976 Selective inhibitors of MMP-12 |
| 03/05/2002 | US6352975 Methods of treating hypertension and compositions for use therein |
| 03/05/2002 | US6352974 Oral calcitonin pharmaceutical compositions and methods of making the same |
| 03/05/2002 | US6352973 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352972 Enhancing bone growth in mammals with bone morphogenic fusion protein |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352970 Treatment of skeletal disorders |
| 03/05/2002 | US6352858 Antisense modulation of BTAK expression |
| 03/05/2002 | US6352857 Treatment of diabetes with synthetic beta cells |
| 03/05/2002 | US6352843 YsxC from Staphylococcus aureus |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352836 Dirofilaria and brugia thioredoxin peroxidase type-2 proteins and uses thereof |
| 03/05/2002 | US6352830 Identify immunosuppressive agents by obtaining cells having a transcription factor and expose the cells to a agent that induces nuclear translocation of the transcription factor; monitor translocation and identify immunosuppressive agents |
| 03/05/2002 | US6352723 Homogenate containing alkali soluble active factor which inhibits antigen-stimulated lymphocyte proliferation but intensifies with mitogen-stimulated proliferation |
| 03/05/2002 | US6352722 Time-release agent comprising trehalose diisobutyrate hexaacetate and fluticasone; drug delivery |
| 03/05/2002 | US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants |
| 03/05/2002 | US6352698 Free radical scavenger, antiallergen, and antiinflammatory agents |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | US6352683 Apparatus and method for the local delivery of drugs |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/05/2002 | CA2191971C Pegylation reagents and compounds formed therewith |
| 03/05/2002 | CA2126465C Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 03/05/2002 | CA2098984C Drug delivery system |
| 03/05/2002 | CA1341345C Expression of foreign genes in drosophila cells |
| 02/28/2002 | WO2002016658A1 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 02/28/2002 | WO2002016657A1 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 02/28/2002 | WO2002016644A1 Inhibition of protein-protein interaction |
| 02/28/2002 | WO2002016632A1 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 02/28/2002 | WO2002016623A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 02/28/2002 | WO2002016617A2 Myrosinase from brevicoryne brassicae |
| 02/28/2002 | WO2002016616A2 Human carboxylesterase family member and uses thereof |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016608A1 New sequences |
| 02/28/2002 | WO2002016607A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/28/2002 | WO2002016603A2 23228, a novel human tetraspanin family member and uses thereof |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016599A2 Proteins and nucleic acids encoding same |
| 02/28/2002 | WO2002016598A2 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016596A2 pRNA CHIMERA |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016593A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016592A2 Atcr-1, a human acyltransferase and uses thereof |
| 02/28/2002 | WO2002016591A2 Human transporter family members and uses thereof |
| 02/28/2002 | WO2002016589A2 Human abc transporter family member and uses thereof |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016582A2 Human sodium-sugar symporter family member and uses thereof |
| 02/28/2002 | WO2002016578A2 Secreted proteins and methods of using same |
| 02/28/2002 | WO2002016576A1 11 human secreted proteins |
| 02/28/2002 | WO2002016575A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 02/28/2002 | WO2002016562A2 22244 and 8701, novel human dehydrogenases and uses thereof |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016551A2 Trance regulation of chondrocyte differentiation |
| 02/28/2002 | WO2002016550A2 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 02/28/2002 | WO2002016549A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 02/28/2002 | WO2002016437A2 Rhabdovirus-based vectors to express high levels of functional human antibodies |
| 02/28/2002 | WO2002016434A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 02/28/2002 | WO2002016431A2 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 02/28/2002 | WO2002016430A2 Peptide with effects on cerebral health |
| 02/28/2002 | WO2002016428A1 Irap-binding protein |
| 02/28/2002 | WO2002016427A1 Crystal structure of a ras-pi3k complex |
| 02/28/2002 | WO2002016426A2 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002016411A2 Binding polypeptides and methods based thereon |